Prostate neoantigens and their uses
US11793843B2 · kind B2 · utility
0Cited by
121References
29Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 9, 2020 |
| Grant date | Oct 24, 2023 |
| Priority date | — |
| Expiry date | Aug 26, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2710/10343
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The disclosure relates to prostate neoantigens, polynucleotides encoding them, vectors, host cells, recombinant virus particles, vaccines comprising the neoantigens, proteinaceous molecules binding the prostate neoantigens, and methods of making and using them.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.